New sponsor, race name for Chase opener
July 30, 2014, Staff report, NASCAR.com
Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR, will serve as the title sponsor for the first Chase for the NASCAR Sprint Cup race of 2014. The MyAFibStory.com 400 takes place at Chicagoland Speedway and concludes a tripleheader weekend.
The race name is in recognition of National AFib Awareness Month, which runs through September. Atrial Fibrillation, or AFib, is a condition caused by an irregular heartbeat that impacts nearly three million Americans.
"The first race in the Chase for the NASCAR Sprint Cup provides a unique and elevated stage within the sport, one that delivers an excellent opportunity to raise awareness of atrial fibrillation with the MyAFibStory.com 400," Chicagoland Speedway President Scott Paddock said in a track release. "We are proud to be partnering with Janssen, and we have a number of events and activation opportunities planned to educate and encourage race fans on AFib, risks and warning signs and treatment for the condition."
Janssen sponsored a NASCAR event earlier this year, the TreatMyClot.com 300 at Auto Club Speedway. It also sponsored Brian Vickers' No. 55 Toyota in the NASCAR Sprint Cup Series race at the same facility.
"Millions of Americans are living with AFib, and could have an increased risk for an AFib-related stroke if it is not being treated properly," Janssen Group Product Director Gregg Ruppersberger said in the release. "That's why we and Chicagoland Speedway are partnering to educate people about the risk factors and warning signs for AFib, stroke, blood clot prevention and treatment options."